Taclonex
INDICATIONS
Taclonex® Ointment is indicated for the topical treatment of psoriasis vulgaris in adults 18 years of age and above for up to 4 weeks. The maximum weekly dose should not exceed 100 g. Treatment of more than 30% body surface area is not recommended.
Taclonex® Ointment should not be applied to the face, axillae or groin.
DOSAGE AND ADMINISTRATION
Apply an adequate layer of Taclonex® Ointment to the affected area(s) once daily for up to 4 weeks. Taclonex® Ointment should be rubbed in gently and completely. The maximum weekly dose should not exceed 100 g. Treatment of more than 30% body surface area is not recommended. Taclonex® Ointment should not be applied to the face, axillae or groin.
HOW SUPPLIED
Taclonex® Ointment (calcipotriene 0.005% and betamethasone dipropionate 0.064%) is available in 60 gram collapsible tubes (NDC 0430-3230-15).
Store Taclonex® Ointment between 20-25°C (68-77°F); excursions permitted between 15-30°C (59-86°F).
Keep out of reach of children.
Manufactured by: LEO Laboratories Ltd. (LEO Pharma) Dublin, Ireland. FDA Rev date: 9/25/2007
Generic Name: Calcipotriene and Betamethasone Dipropionate
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Psoriasis Relief
Until now, there's been no truly effective drug treatment for psoriasis. But an arthritis drug is showing promising results.See more WebMD Videos »
Taclonex
Health Resources
2008 Election & Health Care on WebMD. Get Informed.
Updated & New
RxList does not provide medical advice, diagnosis or treatment.